Clinical trial
PDX-1 and NGN-3 Expression in Gestational Diabetes
NCT03964987 is registered in ClinicalTrials.gov with Materno-Perinatal Hospital of the State of Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PDX-1 and NGN-3 Expression in Gestational Diabetes
- Lead sponsor
- Materno-Perinatal Hospital of the State of Mexico
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- December 31, 2018
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gestational diabetes